Core Viewpoint - Haier Biomedical showcased its prototype of a 100,000 RPM ultra-high-speed centrifuge at the 8th China International Import Expo, marking a significant milestone in China's self-research in ultra-high-speed centrifuge technology [3]. Group 1: Technology Breakthrough - The 100,000 RPM centrifuge can achieve separation of subcellular structures (such as mitochondria and lysosomes), exosome extraction, purification of coronaviruses, and high-precision removal of impurities from quantum dots [5]. - This technology is essential for advanced laboratory applications, including protein complex analysis, exosome research, and biopharmaceutical development [5]. Group 2: Market Landscape - The technology barriers for ultra-high-speed centrifuges include reliance on imported ultra-high-speed motors, insufficient precision titanium alloy rotor processing, low integration of vacuum and cooling systems, and challenges in dynamics and vibration control [7]. - Currently, the global market for 100,000 RPM and above centrifuges is dominated by European and American brands, such as Thermo Fisher's WX series, Beckman Coulter's Optima MAX-XP series, and Eppendorf's CP-NX series [7]. - The breakthrough in the 100,000 RPM ultra-high-speed centrifuge signifies a key step towards self-sufficiency in high-end scientific instruments in China [8].